Einstein Tops $185 Million in NIH Grants in 2021

November 30, 2021—BRONX, NY—Researchers at Albert Einstein College of Medicine received more than $185 million in grants from the National Institutes of Health (NIH) during federal fiscal year 2021, which ended on September 30, capping another successful year in funding for the institution. Notable awards include those for three major research centers, projects investigating the use of medical cannabis for chronic pain, and studies to address health disparities, as well as an NIH Director’s Innovation Award and an Outstanding Investigator Award from the National Cancer Institute.

Dean Gordon F. Tomaselli, M.D.

Gordon F. Tomaselli, M.D.

“Once again, our extraordinary investigators have successfully secured funding to advance our understanding of the science underlying human disease and develop novel diagnostics and treatments for some of the most pressing and intractable medical challenges,” said Gordon F. Tomaselli, M.D., the Marilyn and Stanley M. Katz Dean at Einstein and executive vice president and chief academic officer at Montefiore Medicine. “I applaud their creativity, productivity, and excellence as they pursue their research and further our mission to create new knowledge and improve human health.”

Among the year’s grants are those in which Einstein faculty lead major national projects and centers:

Once again, our extraordinary investigators have successfully secured funding to advance our understanding of the science underlying human disease and develop novel diagnostics and treatments for some of the most pressing and intractable medical challenges.

Dean Gordon F. Tomaselli, M.D.

Two faculty members received prestigious named awards for their research projects:

New major grants for investigator-initiated research projects include:

More News